Sulfuric Acid

Sulfuric Acid

SCHEMBL3336768

CCNc1cc(O)ccc1C.O=S(=O)(O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.83
CYP3A4 P08684 2/20 0.83
RECQL P46063 2/20 0.83
HPGD P15428 2/20 0.45
HIF1A Q16665 2/20 0.45
HSD17B10 Q99714 2/20 0.45
LMNA P02545 1/20 0.45
CYTH2 Q99418 3/20 0.40
RIPK2 O43353 2/20 0.39
RET P07949 2/20 0.39
KDR P35968 1/20 0.39
MAPK14 Q16539 1/20 0.39
PKMYT1 Q99640 1/20 0.39
ALDH1A1 P00352 4/20 0.39
ACHE P22303 1/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
GAA P10253 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126869 0.91 TSHR (1.00) TSHRCYP3A4RECQLHPGDHIF1A
Potassium SCHEMBL30495501 0.89 TSHR (0.96) TSHRCYP3A4RECQLHPGDHIF1A
SCHEMBL28530092 0.89 TSHR (0.96) TSHRCYP3A4RECQLHPGDHIF1A
Potassium SCHEMBL30495500 0.89 TSHR (0.96) TSHRCYP3A4RECQLHPGDHIF1A
Sulfuric Acid SCHEMBL3329752 0.83 CYP3A4 (0.57) TSHRCYP3A4RECQLHPGDHIF1A
Phenol SCHEMBL28238632 0.83 TSHR (0.83) TSHRCYP3A4RECQLHSD17B10LMNA
SCHEMBL6660835 0.79 CYP3A4 (0.56) TSHRCYP3A4RECQLLMNAALDH1A1
SCHEMBL25396737 0.78 CYP3A4 (0.54) TSHRCYP3A4RECQLHPGDHIF1A
SCHEMBL2743946 0.78 CYP3A4 (0.54) TSHRCYP3A4RECQLHPGDHIF1A
SCHEMBL27925196 0.77 CYP3A4 (0.73) TSHRCYP3A4RECQLACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583876-B2 Branched organosilicon compound, method of preparing same, and related compositions DOW SILICONES CORPORATION (US) 2026-03-24 US disclosed
EP-3493878-B1 COSMETIC COMPOSITION COMPRISING CURED SILICONE MATERIALS DOW SILICONES CORP (US) 2025-10-08 EP disclosed
US-12398270-B2 Acrylate-functional branched organosilicon compound, method of preparing same, and copolymer formed therewith DOW SILICONES CORPORATION (US) 2025-08-26 US disclosed
US-12371535-B2 Branched organosilicon compound, method of preparing same, and copolymer formed therewith DOW SILICONES CORPORATION (US) 2025-07-29 US disclosed
US-12338259-B2 Branched organosilicon compound, method of preparing same, and copolymer formed therewith DOW SILICONES CORPORATION (US) 2025-06-24 US disclosed
US-12269833-B2 Branched organosilicon compound, method of preparing same, and compositions comprising same DOW SILICONES CORPORATION (US) 2025-04-08 US disclosed
US-12215198-B2 Branched organosilicon compound, method of preparing same, and compositions comprising same DOW SILICONES CORPORATION (US) 2025-02-04 US disclosed
US-20240245600-A1 ORRIS ROOT EXTRACTS, COMPOSITIONS, AND METHODS FOR SKIN APPLICATIONS ACCESS BUSINESS GROUP INT LLC (US) 2024-07-25 US disclosed
US-11986547-B2 Cosmetic composition comprising silicone materials DOW SILICONES CORPORATION (US) 2024-05-21 US disclosed
CN-117794504-A Iris root extract, compositions and methods for dermatological use 捷通国际有限公司 2024-03-29 CN disclosed
WO-2014081939-A1 COSMETIC COMPOSITION COMPRISING BI-MODAL EMULSION DOW CORNING CORPORATION (US) 2014-05-30 WO disclosed
WO-2014081950-A2 FABRIC CARE COMPOSITIONS COMPRISING EMULSIONS DOW CORNING CORPORATION (US) 2014-05-30 WO disclosed
US-20140127140-A1 Cosmetic Composition Comprising Hydrophilic Organosilanes DOW CORNING CORPORATION (US) 2014-05-08 US disclosed
WO-2014070639-A2 COSMETIC COMPOSITION COMPRISING HYDROPHILIC ORGANOSILANES DOW CORNING CORPORATION (US) 2014-05-08 WO disclosed
US-20130336909-A1 PERSONAL CARE AND HEALTH CARE COMPOSITIONS DOW CORNING CORPORATION (US) 2013-12-19 US disclosed
EP-2663279-A2 PERSONAL CARE COMPOSITIONS Dow Corning Corporation (US) 2013-11-20 EP disclosed
WO-2012095399-A2 PERSONAL CARE AND HEALTH CARE COMPOSITIONS DOW CORNING CORPORATION (US) 2012-07-19 WO disclosed
US-20100143274-A1 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS CIBA CORPORATION (US) 2010-06-10 US disclosed
EP-2120846-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (DE) 2009-11-25 EP disclosed
WO-2008107347-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (CH) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12215198-B2 Branched organosilicon compound, method of preparing same, and compositions comprising same ORC3, OXSR1, OR10J3 TSHR 933/4885CYP3A4 1394/4885RECQL 32/4885
US-20100143274-A1 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS MAOA, MAOB, ACMSD TSHR 2456/4885CYP3A4 360/4885RECQL 774/4885
US-12583876-B2 Branched organosilicon compound, method of preparing same, and related compositions OXSR1, BRS3, NPSR1 TSHR 172/4885CYP3A4 931/4885RECQL 2377/4885
US-12269833-B2 Branched organosilicon compound, method of preparing same, and compositions comprising same NR3C2, NR2E3, OXER1 TSHR 376/4885CYP3A4 1926/4885RECQL 2805/4885
US-12338259-B2 Branched organosilicon compound, method of preparing same, and copolymer formed therewith OXSR1, BRS3, ORC3 TSHR 887/4885CYP3A4 1716/4885RECQL 1276/4885
US-12371535-B2 Branched organosilicon compound, method of preparing same, and copolymer formed therewith OXSR1, BRS3, OXER1 TSHR 187/4885CYP3A4 1178/4885RECQL 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.